Prometheus Biosciences, Inc is a company in the U.S. stock market and it is a holding in 43 U.S.-traded ETFs. RXDX has around 2.4M shares in the U.S. ETF market. The largest ETF holder of RXDX is the iShares Russell 2000 ETF (IWM), with approximately 656.03K shares. Investors may also find of interest that the ETF with the largest allocation to RXDX stock is ALPS Medical Breakthroughs ETF (SBIO), with a portfolio weight of 1.10%. On average, U.S. ETFs allocate 0.11% of RXDX to their portfolios.
Additionally, RXDX is a favorite stock for Vanilla and Active ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with RXDX as a holding is the Humankind U.S. Stock ETF (HKND), with a return of 2.68%.